Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Fallopian Tube Neoplasms 9Ovarian Neoplasms 8Uterine Cervical Neoplasms 6Pancreatic Neoplasms 4Brenner Tumor 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Thymoma 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2HIV Infections 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Endometrial Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Anus Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Urinary Bladder Neoplasms 1Teratoma, Testicular 1Teratoma, Ovarian 1Teratoma 1Sertoli-Leydig Cell Tumor 1

Interventions

Taxes 1Paclitaxel 1Ifosfamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinosarcoma × Taxes × Clear all
NCT00954174 2021-09-30

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

GOG Foundation

Phase 3 Unknown
637 enrolled 18 charts
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡